| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Mar 19, 2024 | Stoke Therapeutics, Inc. | CFO | Sell | 46.3 | -4,116 | -16.56% | ✗ | $25.1K |
| Feb 22, 2021 | Feb 24, 2021 | Stoke Therapeutics, Inc. | CFO | Sell | 5.0 | -30,000 | -70.91% | ✓ | $1.8M |
| Nov 2, 2020 | Nov 4, 2020 | Stoke Therapeutics, Inc. | CFO | Sell | 5.0 | -70,000 | -63.06% | ✓ | $2.7M |
| Feb 17, 2017 | Feb 21, 2017 | Aldeyra Therapeutics, Inc. | CFO | Buy | 91.3 | +3,333 | 100.00% | ✗ | $15K |